Teva Pharmaceutical Industries Ltd.

Major Shareholding Notification • Mar 7, 2018

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden hours
per response	0.5

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person		2. Date of Event Requiring	3. Issuer Name and Ticker or Trading Symbol
Fridriksdottir	Hafrun	Statement (Month/Day/Year)	Teva Pharmaceutical Industries Ltd. [TEVA]
(Last)	(First) (Middle)	01/01/2018	4. Relationship of Reporting Person(s) to 5. If Amendment, Date Original
Basel Street	C/O Teva Pharmaceutical Industries Ltd. , 5		Issuer Filed(Month/Day/Year) (Check all applicable) 01/02/2018 _ Director _ 10% Owner
(Street)			____ Other (specify 6. Individual or Joint/Group Filing (Check X Officer (give title
Petach Tikva	L3 4951033		below) below) Applicable Line) Executive VP, Global R&D X Form filed by One Reporting Person
(City)	(State) (Zip)		____ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)		Owned	2. Amount of Securities Beneficially 3. Ownership 4. Nature of Indirect Beneficial Ownership Form: Direct (D) (Instr. 5)

or Indirect (I) (Instr. 5)

(Instr. 4)

Ordinary Shares (1) 3,344.514 (2) D

Table II - Derivative Securities Beneficially Owned ( e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative	5. Ownership Form of Ownership Derivative (Instr. 5)	6. Nature of Indirect Beneficial
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	Security Security: Direct (D) or Indirect (I) (Instr. 5)

Explanation of Responses:

• (1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
• (2) This Amendment to Form 3 filed on January 2, 2018 is being filed solely to correct the number of Ordinary Shares owned by the Reporting Person.

Remarks:

The Reporting Person is filing this form in connection with the Issuer's transition from a foreign private issuer to a domestic issuer, effective January 1, 2018.

/s/ Dov Bergwerk, as attorney-in-fact for Hafrun Fridriksdottir 03/06/2018

**Signature of Reporting Person Date

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.